Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival
Publication date
2015
Authors
Lokhorst, Henk M.
Van Der Holt, Bronno
Cornelissen, Jan J.
Kersten, Marie José
Van Oers, Marinus
Raijmakers, Reinier
Minnema, Monique C.
Zweegman, Sonja
Bos, Gerard
Schaap, Nicolaas
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Allogeneic stem cell transplantation, Myeloma, Prognosis, Taverne, Hematology, Clinical Trial, Comparative Study, Letter, Research Support, Non-U.S. Gov't
Citation
Lokhorst, H M, Van Der Holt, B, Cornelissen, J J, Kersten, M J, Van Oers, M, Raijmakers, R, Minnema, M C, Zweegman, S, Bos, G, Schaap, N, Wittebol, S, de Weerdt, O, Ammerlaan, R & Sonneveld, P 2015, 'Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival', Haematologica, vol. 100, no. 12, pp. e508-e510. https://doi.org/10.3324/haematol.2015.128728